SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
DODD_NASOPHARYNGEAL_CARCINOMA_DN
MODULE_54
KOBAYASHI_EGFR_SIGNALING_24HR_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP
MARSON_BOUND_BY_E2F4_UNSTIMULATED
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
HORIUCHI_WTAP_TARGETS_DN
BASAKI_YBX1_TARGETS_UP
VECCHI_GASTRIC_CANCER_EARLY_UP
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN
BENPORATH_CYCLING_GENES
KONG_E2F3_TARGETS
CHANG_CYCLING_GENES
NUYTTEN_EZH2_TARGETS_DN
BERENJENO_TRANSFORMED_BY_RHOA_UP
ODONNELL_TFRC_TARGETS_DN
ZHANG_TLX_TARGETS_60HR_DN
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
LEE_EARLY_T_LYMPHOCYTE_UP
GOLDRATH_ANTIGEN_RESPONSE
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
SMID_BREAST_CANCER_BASAL_UP
CAIRO_HEPATOBLASTOMA_CLASSES_UP
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
CROONQUIST_IL6_DEPRIVATION_DN
WINNEPENNINCKX_MELANOMA_METASTASIS_UP
BLUM_RESPONSE_TO_SALIRASIB_DN
GAVIN_FOXP3_TARGETS_CLUSTER_P6
MARKEY_RB1_ACUTE_LOF_DN
WHITFIELD_CELL_CYCLE_G2_M
PUJANA_BRCA1_PCC_NETWORK
CROONQUIST_NRAS_SIGNALING_DN
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
FOURNIER_ACINAR_DEVELOPMENT_LATE_2
PUJANA_CHEK2_PCC_NETWORK
ZHANG_TLX_TARGETS_36HR_DN
PATIL_LIVER_CANCER
KANG_DOXORUBICIN_RESISTANCE_UP
ZHAN_MULTIPLE_MYELOMA_PR_UP
KRIEG_HYPOXIA_NOT_VIA_KDM3A
PUJANA_BRCA2_PCC_NETWORK
MISSIAGLIA_REGULATED_BY_METHYLATION_DN
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
REACTOME_CELL_CYCLE
BURTON_ADIPOGENESIS_3
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
WONG_EMBRYONIC_STEM_CELL_CORE
MORI_IMMATURE_B_LYMPHOCYTE_DN
FUJII_YBX1_TARGETS_DN
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP
MITSIADES_RESPONSE_TO_APLIDIN_DN
ZHENG_GLIOBLASTOMA_PLASTICITY_UP
FURUKAWA_DUSP6_TARGETS_PCI35_DN
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN
MODULE_118
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN
WEST_ADRENOCORTICAL_TUMOR_UP
MODULE_52
WHITEFORD_PEDIATRIC_CANCER_MARKERS
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN
SHEPARD_CRUSH_AND_BURN_MUTANT_DN
JOHNSTONE_PARVB_TARGETS_3_DN
REACTOME_CELL_CYCLE_MITOTIC
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
LE_EGR2_TARGETS_UP
FEVR_CTNNB1_TARGETS_DN
BENPORATH_PROLIFERATION
MODULE_198
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN
MODULE_18
KIM_WT1_TARGETS_DN
TANG_SENESCENCE_TP53_TARGETS_DN
POOLA_INVASIVE_BREAST_CANCER_UP
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN
RUIZ_TNC_TARGETS_DN
BIDUS_METASTASIS_UP
BENPORATH_ES_1
MODULE_3
MODULE_98
GEORGES_TARGETS_OF_MIR192_AND_MIR215
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53
MODULE_252
RHODES_UNDIFFERENTIATED_CANCER
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR
REICHERT_MITOSIS_LIN9_TARGETS
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
CHICAS_RB1_TARGETS_GROWING
ZHANG_TLX_TARGETS_UP
WILCOX_RESPONSE_TO_PROGESTERONE_UP
AFFAR_YY1_TARGETS_DN
